hypertension

Pharma

Alcon is adding 2 more arrows to its opthalmic eye drop quiver

The buyout will let Alcon get its hands on Aerie’s marketed glaucoma and ocular hypertension meds Rhopressa and Rocklatan.  
Fraiser Kansteiner Aug 23, 2022 9:24am

Sanofi pulls hypertension meds in Korea, Canada and the U.K.

Aug 10, 2021 9:14am

Alnylam takes biannual hypertension prospect into phase 2 trial

Jul 6, 2021 7:40am

Labeling error prompts recall of Alembic hypertension med

Mar 25, 2021 8:16am

Boehringer Ingelheim halted production of Catapres for good

Jan 8, 2021 10:56am

AstraZeneca resumes closet cleanout with $400M Atacand deal

Oct 30, 2020 11:32am